miR-21 can target phosphatase and tensin homolog, which are involved in hepatic steatosis prevention, and PPARα expression, which activates lipid oxidation and determines inflammation and fibrosis progression in NAFLD [28]. The gene discussed is PTEN; the disease is metabolic dysfunction-associated steatotic liver disease.